SCHEMBL5354726

SCHEMBL5354726

N#CCC(=O)OC1CCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.40
CYP19A1 P11511 2/20 0.39
EPHX1 P07099 2/20 0.36
ALDH1A1 P00352 4/20 0.35
POLB P06746 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 2/20 0.35
MAPT P10636 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MCL1 Q07820 1/20 0.34
KMT2A Q03164 2/20 0.34
GAA P10253 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5348431 0.96 NAAA (0.46) NAAACYP2C19HTTCYP19A1EPHX1
SCHEMBL5357978 0.94 CYP2C19 (0.49) NAAACYP2C19HTTCYP19A1EPHX1
SCHEMBL5348250 0.91
SCHEMBL9345676 0.82 MAP3K5 (0.33) NAAACYP2C19EPHX1TSHRMCL1
SCHEMBL8346264 0.78 APOBEC3A (0.52) NAAACYP2C19HTTCYP19A1EPHX1
SCHEMBL11418612 0.78 APOBEC3A (0.42) NAAAHTTCYP19A1ALDH1A1SMN1; SMN2
SCHEMBL3368606 0.78 MCL1 (0.33) MCL1KMT2A
SCHEMBL9646620 0.77 NAAA (0.38) NAAAHTTCYP19A1ALDH1A1SMN1; SMN2
SCHEMBL13696684 0.76 MAPT (0.42) CYP2C19ALDH1A1SMN1; SMN2MAPTKDM4E
SCHEMBL4468616 0.75 CYP2C19 (0.50) NAAACYP2C19HTTCYP19A1EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7300953-B2 Process for preparing nitrile compound, carboxylic acid compound or carboxylic acid ester compound UBE INDUSTRIES, LTD (JP) 2007-11-27 US disclosed
US-20060287541-A1 Subjecting a 4-substituted tetrahydropyran-4-carboxylic acid compound to to decarboxylation in the presence of a metal catalyst for producing 4-substituted tetrahydropyran UBE INDUSTRIES, LTD. (JP) 2006-12-21 US disclosed
EP-1671937-A1 METHOD FOR PRODUCING NITRILE COMPOUND, CARBOXYLIC ACID COMPOUND OR CARBOXYLATE COMPOUND Ube Industries, Ltd. (JP) 2006-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287541-A1 Subjecting a 4-substituted tetrahydropyran-4-carboxylic acid compound to to decarboxylation in the presence of a metal catalyst for producing 4-substituted tetrahydropyran CBR1, ALDH18A1, ME1 NAAA 30/4885CYP2C19 98/4885HTT 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.